Cansino Biologics Inc
688185Pharmaceuticals
CN¥73.80−5.74%As of Oct 29vs prior close
- Market cap
- $1.3B
- P/E (TTM)
- 492.0×
- P/E (FY1)
- 461.3×
- From 52W high
- −28.10%
- EPS (LTM)
- CN¥0.16
- Revenue (LTM)
- CN¥1.2B
- Net margin
- 2.36%
Nomior Score
44
Steady ProfileBottom 36% of the scored universe
Growth58
Quality42
Value36
Momentum59
Resilience40
Growth
+0.91%revenue a year over 3 fiscal years
YE22 CN¥1BLTM CN¥1.2B
Connections
Revenue to profitYE25
3% of revenue became net profit, up 49 pts on a year.